Method and products for treating diabetes
AssigneeCBA Pharma, Inc.
InventorJames A. Mitchell
Life of this patent
Estimating the term…
Abstract
Treating diabetes by administering one or more members of the d-tetrandrine family, either alone or with other Type 2 diabetes drugs or dietary supplements which mediate diabetes.
Claims20
A method of treating Type 2 diabetes comprising:
- administering to a patient with Type 2 diabetes a member of the d-tetrandrine family of drugs having the following structural formula:
- where R1 and R1′ are the same or different short chained carbon based ligand including without limitation, CH3, CO2CH3 or H;
- and R2 is CH3 or C2H5;
- and R3 is CH3 or hydrogen, and wherein said structural formula has the “S” isomeric configuration at the C-1′ chiral carbon location.
A pharmaceutical composition for treating Type 2 diabetes, comprising a Type 2 diabetes medication and/or dietary supplement which mediates diabetes, combined with a member of the d-tetrandrine family having the following structural formula:
- where R1 and R1′ are the same or different short chained carbon based ligand including without limitation, CH3, CO2CH3 or H;
- and R2 is CH3 or C2H5;
- and R3 is CH3 or hydrogen, and wherein said structural formula has the “S” isomeric configuration at the C-1′ chiral carbon location.
A pharmaceutical kit for treating Type 2 diabetes, including a Type 2 diabetes medication and/or dietary supplement which mediates diabetes, and a formulation comprising a member of the d-tetrandrine family having the following structural formula:
- where R1 and R1′ are the same or different short chained carbon based ligand including without limitation, CH3, CO2CH3 or H;
- and R2 is CH3 or C2H5;
- and R3 is CH3 or hydrogen, and wherein said structural formula has the “S” isomeric configuration at the C-1′ chiral carbon location.
Dependencies are inferred from the claim text.